Expertise in
12
conditions

Uwe R. Kordes

Hamburg, HH, DE 
Expertise in
12
conditions
Hamburg, HH, DE 

Overview

Uwe Kordes practices practicing medicine in Hamburg, Germany.

Mr. Kordes is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Rhabdoid Tumor Predisposition Syndrome, Rhabdoid Tumor, Cerebral Ventricle Cancer, Choroid Plexus Carcinoma, and Small Bowel Resection.

He is actively involved in clinical research, co-authoring 69 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Hamburg, HH 20251, Germany
Other Locations
Eppendorf, HH, Germany
Muenster, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Desmoplastic Small Round Cell Tumor
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Desmoplastic Small Round Cell Tumor
Enrollment Status: Completed
Publish Date: August 07, 2026
Intervention Type: Drug
Study Drugs: Ramucirumab, Cyclophosphamide, Vinorelbine
Study Phase: Phase 1/Phase 2
Single-arm, Multicenter Phase I/Ib Study of Avelumab + Lenvatinib in Children With Primary CNS Tumors
Single-arm, Multicenter Phase I/Ib Study of Avelumab + Lenvatinib in Children With Primary CNS Tumors
Enrollment Status: Terminated
Publish Date: July 29, 2026
Intervention Type: Drug
Study Phase: Phase 1
B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
B-NHL 2013 - Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
Enrollment Status: Active_not_recruiting
Publish Date: April 30, 2026
Intervention Type: Drug
Study Drugs: Rituximab, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin, Vindesine, Etoposide, Ifosfamide, Methotrexate, Prednisolone, Vincristine
Study Phase: Phase 3
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
Enrollment Status: Unknown
Publish Date: August 27, 2024
Intervention Type: Drug
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Synovial Sarcoma
A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Synovial Sarcoma
Enrollment Status: Terminated
Publish Date: September 13, 2023
Intervention Type: Drug
Study Drugs: Ramucirumab, Gemcitabine, Docetaxel
Study Phase: Phase 1/Phase 2
View 4 Less Clinical Trials

69 Total Publications

Overactivation of SHH signaling induces a cascade of dedifferentiation and oncogenesis in a new mouse model for choroid plexus carcinoma.
Overactivation of SHH signaling induces a cascade of dedifferentiation and oncogenesis in a new mouse model for choroid plexus carcinoma.
Journal: Acta neuropathologica communications
Published: February 24, 2026

Frequently Asked Questions about Uwe R. Kordes

Is Uwe R. Kordes a top-rated expert for Rhabdoid Tumor Predisposition Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Uwe R. Kordes is classified as an Elite expert for Rhabdoid Tumor Predisposition Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Uwe R. Kordes participate in research or clinical trials?

Yes. Uwe R. Kordes has published 69 articles and abstracts on conditions like Rhabdoid Tumor Predisposition Syndrome. You can view a list of Uwe R. Kordes's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kordes's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile